Laura Belloli

  • Citations Per Year
Learn More
Sir, The recently published paper of Caramaschi et al. [1], who reported very low levels of vitamin D in systemic sclerosis (SSc), prompted us to report our data. We studied the serum levels of vitamin D in a cohort of 43 North Italian patients with SSc (age 61±14 years, 42 females, 29 with limited SSc, 11 with diffuse SSc, three with SSc sine scleroderma).(More)
OBJECTIVE To identify clinical and/or laboratory characteristics that could be risk factors for myocardial microvascular involvement in patients with SSc. METHODS Twenty-one SSc patients, clinically silent for cardiovascular disease, were consecutively evaluated for myocardial perfusion defects through 99m-Tc sestamibi gated myocardial perfusion SPECT(More)
INTRODUCTION The risk of cancer with the use of biologic agents in rheumatic diseases is still a matter of debate. Published data suggest that the extent of cancer risk might differ according to the type of cancer, and there is recent clinical evidence for a significant increased risk for skin cancer, including melanoma. In contrast with the extensive(More)
Dear Editor, The recent paper of Choi HJ et al. [1] suggesting that NTproBNP may be a biological marker of skin fibrosis in systemic sclerosis (SSc), prompted us to report our data. We studied 16 SSc patients (15 females, one male) according to the criteria of the American College of Rheumatology [2], aged 57±15 years, 13 patients with limited SSc and three(More)
To review recent advances and current controversies on the association between systemic sclerosis (SSc) and cancer, PUBMED was searched from 1966 to the present using the terms: systemic sclerosis, cancer, morphoea, sclerotic diseases. Malignancies, mainly in lung and breast, coexist with idiopathic SSc or with SSc-like disorders, but not with localized(More)
Sir, The recently published paper of Habib and Safia [1] on the effect of intra-articular corticosteroid injections (IASI) on glucose blood levels prompted us to report our data. We studied 16 patients who needed IASI for inflammatory arthritis; 12 were non-diabetic subjects (age 58±14 years, mean ± SD, two men and ten women) and four patients had diabetes(More)